CLINICAL ROLE -
Approval of Tapinarof Introduces New Class of Topical Treatments for Management of Plaque Psoriasis
Tapinarof is a first-in-class topical steroid-free aryl hydrocarbon receptor antagonist intended to mitigate the symptoms of plaque psoriasis.
Ongoing Developments and Barriers for Treatment of Alzheimer Disease
It is the responsibility of the pharmacist to remain informed of all existing and new drugs for the treatment of Alzheimer disease, especially because novel and investigational drugs may target the pathophysiology of the disease.
Pharmacologic Treatment of Migraine: Current and Emerging Therapies
Pharmacists should assess patient comorbidities, symptoms, and history to ensure the selection of the most appropriate migraine medication.
2 Clarke Drive Cranbury, NJ 08512